SCHEMBL20137423

SCHEMBL20137423

NC1(CC(=O)O)CCCc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HDAC9 Q9UKV0 1/20 0.42
KIF11 P52732 1/20 0.41
SIGMAR1 Q99720 3/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
DRD2 P14416 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR2B P41595 1/20 0.40
MTOR P42345 1/20 0.40
AKR1B1 P15121 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28901494 1.00 KDM1A (0.46) KDM1AMEN1KMT2AHDAC9KIF11
SCHEMBL4735703 0.90 HDAC9 (0.44) KDM1AHDAC9KIF11SIGMAR1TP53
SCHEMBL4737865 0.90 HDAC9 (0.44) KDM1AHDAC9KIF11SIGMAR1TP53
SCHEMBL390762 0.82 ALDH1A1 (0.42) KDM1AMEN1KMT2AHDAC9KIF11
SCHEMBL20137430 0.82 KMT2A (0.47) KDM1AMEN1KMT2AHDAC9
SCHEMBL30995679 0.82 KMT2A (0.47) KDM1AMEN1KMT2AHDAC9
SCHEMBL20137431 0.82 KMT2A (0.47) KDM1AMEN1KMT2AHDAC9
SCHEMBL26692976 0.81 MEN1 (0.46) KDM1AMEN1KMT2ASIGMAR1
SCHEMBL20137432 0.80 KDM4C (0.38) KDM1AMEN1KMT2ASIGMAR1RAD52
SCHEMBL28478058 0.80 KDM4C (0.41) SIGMAR1CYP1A2TSHRBLMRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12006323-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2024-06-11 US disclosed
US-11034699-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2021-06-15 US disclosed
CN-107580598-B Ethynyl derivatives as metabotropic glutamate receptor modulators 豪夫迈·罗氏有限公司 2020-11-13 CN disclosed
EP-3322701-B1 ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS HOFFMANN LA ROCHE (CH) 2019-05-01 EP disclosed
US-20190119290-A1 ETHYNYL DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2019-04-25 US disclosed
US-10189848-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2019-01-29 US disclosed
US-20180134721-A1 ETHYNYL DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034699-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM1A 3980/4885MEN1 2270/4885KMT2A 1371/4885
US-20180134721-A1 ETHYNYL DERIVATIVES GRM4, GRM2, GRIA4 KDM1A 3980/4885MEN1 2270/4885KMT2A 1371/4885
US-20190119290-A1 ETHYNYL DERIVATIVES GRM4, GRM2, GRIA4 KDM1A 3980/4885MEN1 2270/4885KMT2A 1371/4885
US-12006323-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM1A 3980/4885MEN1 2270/4885KMT2A 1371/4885
US-10189848-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM1A 3980/4885MEN1 2270/4885KMT2A 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.